EMBO Press has chosen Springer Nature to be their new publishing partner, effective January 1, 2024. Authors who publish in EMBO Press journals will benefit from the global reach of Springer Nature’s leading journals. In addition, authors will have the option to transfer manuscripts between journals in the EMBO Press and Springer Nature portfolios.
This announcement follows EMBO Press’ recent decision that to advance global discoverability, transparency, and availability of published research outcomes all papers will be published with full gold Open Access (OA) from 2024, and curated source data will be posted with fully reproducible methods.
This reflects Springer Nature’s own long-held commitment to and experience in advancing Open Access, its experience in developing innovative new routes to OA via transformative agreements and transformative journals, as well as its wider commitment to making all elements of research open, including data, code and protocols.
The journals, The EMBO Journal, EMBO Reports, EMBO Molecular Medicine, and Molecular Systems Biology, which publish high-value articles with important advances in all areas of biology and biomedical sciences from around the globe, join Springer Nature’s leading portfolio of around 600 fully OA journals, including Nature Communications, and over 1,700 hybrid journals which include Nature and the Nature research titles.
Click here to read the original press release.
